Reuters logo
BRIEF-CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products
June 12, 2017 / 11:45 PM / 6 months ago

BRIEF-CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products

June 12 (Reuters) - CSL Ltd:

* CSL to acquire majority stake in chinese plasma fractionator Wuhan Zhong Yuan Rui De Biologicals Products Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below